Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9601 | 1072 | 47.2 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DC SIGN | Author keyword | 117 | 57% | 13% | 138 |
2 | DC SIGNR | Author keyword | 57 | 95% | 2% | 19 |
3 | L SIGN | Author keyword | 19 | 80% | 1% | 12 |
4 | MOL CELL BIOL IMMUNOL | Address | 12 | 14% | 8% | 82 |
5 | TRANS INFECTION | Author keyword | 9 | 64% | 1% | 9 |
6 | C TYPE LECTIN | Author keyword | 9 | 14% | 5% | 57 |
7 | C TYPE LECTINS | Author keyword | 9 | 27% | 3% | 27 |
8 | LSECTIN | Author keyword | 8 | 100% | 0% | 5 |
9 | CD209 | Author keyword | 7 | 44% | 1% | 12 |
10 | SIGNR1 | Author keyword | 7 | 57% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DC SIGN | 117 | 57% | 13% | 138 | Search DC+SIGN | Search DC+SIGN |
2 | DC SIGNR | 57 | 95% | 2% | 19 | Search DC+SIGNR | Search DC+SIGNR |
3 | L SIGN | 19 | 80% | 1% | 12 | Search L+SIGN | Search L+SIGN |
4 | TRANS INFECTION | 9 | 64% | 1% | 9 | Search TRANS+INFECTION | Search TRANS+INFECTION |
5 | C TYPE LECTIN | 9 | 14% | 5% | 57 | Search C+TYPE+LECTIN | Search C+TYPE+LECTIN |
6 | C TYPE LECTINS | 9 | 27% | 3% | 27 | Search C+TYPE+LECTINS | Search C+TYPE+LECTINS |
7 | LSECTIN | 8 | 100% | 0% | 5 | Search LSECTIN | Search LSECTIN |
8 | CD209 | 7 | 44% | 1% | 12 | Search CD209 | Search CD209 |
9 | SIGNR1 | 7 | 57% | 1% | 8 | Search SIGNR1 | Search SIGNR1 |
10 | DCIR | 5 | 63% | 0% | 5 | Search DCIR | Search DCIR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANS INFECTION | 79 | 59% | 8% | 89 |
2 | DC SIGN | 59 | 19% | 26% | 284 |
3 | C TYPE LECTIN | 33 | 16% | 17% | 187 |
4 | EFFICIENTLY TRANSMIT | 27 | 92% | 1% | 11 |
5 | NONINTEGRIN | 23 | 62% | 2% | 24 |
6 | ADHESION MOLECULE 3 GRABBING NONINTEGRIN | 21 | 73% | 1% | 16 |
7 | INTRAVAGINAL INOCULATION | 20 | 30% | 5% | 54 |
8 | SIGN MEDIATED INTERNALIZATION | 19 | 74% | 1% | 14 |
9 | TUMORICIDAL MACROPHAGES | 19 | 74% | 1% | 14 |
10 | CHEMOKINE CORECEPTORS | 18 | 83% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation | 2013 | 22 | 5 | 80% |
Dendritic-cell interactions with HIV: infection and viral dissemination | 2006 | 254 | 122 | 61% |
The physiological role of DC-SIGN: A tale of mice and men | 2013 | 14 | 44 | 84% |
Signaling by Myeloid C-Type Lectin Receptors in Immunity and Homeostasis | 2012 | 109 | 215 | 26% |
C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity | 2010 | 68 | 93 | 48% |
The interaction of HIV with dendritic cells: outcomes and pathways | 2007 | 103 | 101 | 59% |
Distinct roles for DC-SIGN(+)-dendritic cells and Langerhans cells in HIV-1 transmission | 2008 | 58 | 51 | 63% |
DC-sign: Escape mechanism for pathogens | 2003 | 468 | 135 | 47% |
Targeting C-type lectin receptors with multivalent carbohydrate ligands | 2013 | 29 | 137 | 30% |
The Achilles heel of the Trojan horse model of HIV-1 trans-infection | 2008 | 39 | 68 | 76% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL CELL BIOL IMMUNOL | 12 | 14% | 7.6% | 82 |
2 | GLYCOSYST | 6 | 41% | 1.0% | 11 |
3 | CANC BIOL MOL IMMUNOL | 6 | 20% | 2.4% | 26 |
4 | GRP VIRUS IMMUNITE | 5 | 63% | 0.5% | 5 |
5 | CHRIS BROWNE IMMUNOL IMMUNE DIS | 4 | 21% | 1.4% | 15 |
6 | IDM S | 3 | 100% | 0.3% | 3 |
7 | RECH ARTHRITE INFLAMMAT | 3 | 60% | 0.3% | 3 |
8 | INVEST CIENCIES SALUT GERMANS TRIAS PUJOL | 2 | 23% | 0.8% | 9 |
9 | SYST LIFE SCI BIOSTUDIESSAKYO KU | 2 | 67% | 0.2% | 2 |
10 | UNIDAD INMUNOONCOL | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189830 | PLASMACYTOID DENDRITIC CELLS//BDCA 4//PLASMACYTOID DENDRITIC CELL |
2 | 0.0000139866 | MANNOSE RECEPTOR//ENDO180//UPARAP |
3 | 0.0000104144 | CROSS PRESENTATION//CHRIS BROWNE IMMUNOL IMMUNE DIS//CD207 |
4 | 0.0000100434 | ANTI R7V ANTIBODIES//C ADE//T CELL INFECTION |
5 | 0.0000075334 | DENDRITIC CELLS//DENDRITIC CELL//TUMOR LYSATE |
6 | 0.0000058154 | MICROBICIDE//MICROBICIDES//NONOXYNOL 9 |
7 | 0.0000057048 | LANGERHANS CELLS//DERMATOPATHIC LYMPHADENITIS//EMBRYONAL HISTOGENESIS |
8 | 0.0000054987 | SERV REG MALAD INFECT//EQUIPE INTERFERON CYTOKINES//PHARMA NEW TECHNOL |
9 | 0.0000054208 | EXPOSED UNINFECTED//HESN//IMMUNOBIOL HIV UNIT |
10 | 0.0000053405 | CYANOVIRIN N//CV N//ACTINOHIVIN |